TaiCon Bio Announces Board Approval of Q1 2026 Consolidated Financial Report

1. Date of Board of Directors Meeting or Resolution: 115/05/12 2. Date Approved by Audit Committee: 115/05/12 3. Reporting Period for Financial Report or Self-Assessed Annual Financial Information (XXX/XX/XX~XXX/XX/XX): 115/01/01~115/03/31 4. Cumulative Operating Revenue from January 1 to this Period (K): 308,435 5. Cumulative Gross Profit (or Loss) from January 1 to this Period (K): 64,956 6. Cumulative Operating Profit (or Loss) from January 1 to this Period (K): (207,240) 7. Cumulative Profit (or Loss) Before Tax from January 1 to this Period (K): (141,836) 8. Cumulative Net Profit (or Loss) for this Period from January 1 to this Period (K): (142,242) 9. Cumulative Net Profit (or Loss) Attributable to Parent Company Owners from January 1 to this Period (K): (142,242) 10. Cumulative Basic Earnings Per Share (Loss) (Yuan): (0.47) 11. Total Assets at End of Period (K): 10,619,357 12. Total Liabilities at End of Period (K): 2,413,133 13. Equity Attributable to Parent Company Owners at End of Period (K): 8,206,224 14. Other Disclosures: None